Skip to main content

Febit Biotech

Premium
Febit Biotech this week launched its 3’-Inversed Synthesis Set for reverse synthesis of DNA oligonucleotides on arrays used with its Geniom system.
 
Using the 3’-Inversed Synthesis Set customers can now directly apply enzymes to Geniom arrays. The company added that oligonucleotides with a free 3´end are accessible to nucleic acid polymerases and could serve as primers for polymerase-based assays.
 
“The fields of application [for this chip] are diverse, and include all major markets for RT-qPCR” including environmental testing, biodefense, and molecular diagnostics, a Febit spokesperson told BioArray News this week.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.